Hepatic steatosis in diabetic patients does not predict adverse liver-related or cardiovascular outcomes

Liver International

Volumn 33, Issue 10, 2013, Pages 1575-1582

  Dunn, Michael A ^a,b   Behari, Jaideep ^a   Rogal, Shari S ^a   O'Connell, Michael R ^a   Furlan, Alessandro ^b   Aghayev, Ayaz ^b   Gumus, Serter ^b   Saul, Melissa I ^b   Bae, Kyongtae T ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; NAFLD; NASH; Steatosis

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; FATTY LIVER; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HEPATIC ENCEPHALOPATHY; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; SENSITIVITY AND SPECIFICITY; SPLEEN;

DIABETES; NAFLD; NASH; STEATOSIS;

AGE FACTORS; COHORT STUDIES; DIABETES COMPLICATIONS; FATTY LIVER; HUMANS; PENNSYLVANIA; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84885172492     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12285     Document Type: Article

References (23)

1. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-21.
2. Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30: 1212-8.
3. Stepanova M, Younossi Z. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol 2012; 10: 646-50.
4. Li X, Xia M, Ma H, et al. Liver fat content is associated with increased carotid atherosclerosis in a Chinese middle-aged and elderly population: the Shanghai Changfeng study. Atherosclerosis 2012; 224: 480-5.
5. Choi S-Y, Kim D, Kim HJ, et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am J Gastroenterol 2009; 104: 1953-60.
6. Sunga KC, Ryan MC, Wilson AM. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. Atherosclerosis 2009; 203: 581-6.
7. Takeuchi Y, Ito H, Komatsu Y, et al. Non-alcoholic fatty liver disease is an independent predictor for macroangiopathy in Japanese type 2 diabetic patients: a cross-sectional study. Intern Med 2012; 51: 1667-75.
8. Adams LA, Harmsen S, St Sauver JL, et al. Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am J Gastroenterol 2010; 105: 1567-73.
9. Bendtsen F, Dam-Larsen S. Long-term clinical follow-up in fatty liver patients. Dig Dis 2010; 28: 709-14.
10. Coracina A, Gaiani S, Cosma A, et al. No association between the degree of liver steatosis and early signs of vasculopathy in T2DM. Nutr Metab Cardiovasc Dis 2012; 22: e11-2.
11. Cakir E, Ozbek M, Colak N, et al. Is NAFLD an independent risk factor for increased IMT in T2DM? Minerva Endocrinol 2012; 37: 187-93.
12. Petit JM, Guiu B, Terriat B, et al. Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients. J Clin Endocrinol Metab 2009; 94: 4103-6.
13. Yount RJ, Vries JK, Councill CD. The Medical Archival Retrieval System: an information retrieval system based on distributed parallel processing. Inform Process Manag 1991; 27: 1-11.
14. Park SH, Kim PN, Kim KW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006; 239: 105-12.
15. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2012.
16. Powell EE, Cooksley WGE, Hanson R, et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80.
17. van der Poorten D, Samer CF, Ramezani-Moghadam M, et al. Hepatic fat loss in advanced NASH: are alterations in serum adiponectin the cause? Hepatology 2013; 57: 2180-8.
18. Torres DM, Williams CD, Harrison SA. Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012; 10: 837-58.
19. Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011; 54: 1082-90.
20. Bohte AE, Koot BGP, van der Baan-Slootweg OH, et al. US cannot be used to predict the presence or severity of hepatic steatosis in severely obese adolescents. Radiology 2012; 262: 327-34.
21. Wu J, You J, Yerian L, et al. Revalence of liver steatosis and fibrosis and the diagnostic accuracy of ultrasound in bariatric surgery patients. Obes Surg 2012; 22: 240-7.
22. Pickhardt PJ, Park SH, Hahn L, et al. Specificity of unenhanced CT for noninvasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. Eur Radiol 2012; 22: 1075-82.
23. Boyce CJ, Pickhardt PJ, Kim DH, et al. Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. Am J Roentgenol 2010; 194: 623-8.